Arterial-Phase Enhancement Patterns of Hepatocellular Carcinoma: From Pathologic Background to Prognostication and Treatment Response
Open Access
- 15 July 2026
- journal article
- Published by The Korean Society of Abdominal Radiology in Korean Journal of Abdominal Radiology
- Vol. 9 (1) , 14-31
Abstract
Arterial-phase hyperenhancement (APHE), which reflects the hemodynamic shift toward an unpaired arterial supply during hepatocarcinogenesis, is one of the most important imaging features for noninvasive diagnosis of hepatocellular carcinoma (HCC). Although the classic non-rim APHE remains the cornerstone of diagnosis, various enhancement patterns have emerged as critical biomarkers for tumor biology and prognosis. This review provides a comprehensive overview of APHE, tracing its historical development alongside technical advancements in angiography, computed tomography, and magnetic resonance imaging, and explores the pathological and genetic backgrounds of APHE. We categorized distinct enhancement phenotypes, including rim APHE, Kawamura classification, arterial-phase hypoenhancing component, intratumoral artery, and arterial-phase peritumoral enhancement. These patterns serve as imaging surrogates for aggressive clinicopathological traits, such as microvascular invasion, the macrotrabecular-massive subtype, the vessels encapsulating tumor cluster pattern, and TP53 mutation. Furthermore, we discuss how these arterial enhancement patterns guide treatment strategies and predict outcomes of surgical resection, locoregional therapies, and contemporary systemic treatments. Understanding the relationship between diverse enhancement patterns and HCC biology is vital for optimizing therapeutic decision-making.Keywords
Funding Information
- National Research Foundation of Korea (RS-2023-00208307)
- Ministry of Science and ICT, South Korea
This publication has 109 references indexed in Scilit:
- Immunovascular classification of HCC reflects reciprocal interaction between immune and angiogenic tumor microenvironmentsHepatology, 2021
- LI‐RADS 2017: An updateJournal of Magnetic Resonance Imaging, 2018
- Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology, 2018
- A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinomaHepatology, 2015
- Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinomaAbdominal Radiology, 2015
- Gadoxetic acid‐enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteriaJournal of Magnetic Resonance Imaging, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia # †Hepatology, 2009
- Vascular Changes in Hepatocellular CarcinomaThe Anatomical Record, 2008
- Management of Hepatocellular Carcinoma *Hepatology, 2005